Skip to main content

Table 2 Difference between viral suppression of patients sampled at a single time point and durable viral suppression

From: Changing how the third 95 is counted: suitable indicators for measuring U = U with findings from Taiwan

Variable

Total

 

Final viral load test

(< 200 copies/ml) (A)

 

Durable viral suppression

(< 200 copies/ml) (B)

 

Relative difference

N

%

 

n

%

 

n

%

 

\(\left(\frac{(B-A)}{A}\right)\times 100\)

Total

27,706

100.0

 

26,602

96.0

 

24,133

87.1

 

-9.3

Sex

          

Female

1,304

4.7

 

1,227

4.6

 

1,094

4.5

 

-10.8

Male

26,402

95.3

 

25,375

95.4

 

23,039

95.5

 

-9.2

Age when infection was reported

          

<20

823

3.0

 

768

2.9

 

671

2.8

 

-12.6

20–29

13,094

47.3

 

12,479

46.9

 

11,227

46.5

 

-10.0

30–39

9,110

32.9

 

8,800

33.1

 

8,010

33.2

 

-9.0

40–49

3,405

12.3

 

3,317

12.5

 

3,070

12.7

 

-7.4

>=50

1,274

4.6

 

1,238

4.7

 

1,155

4.8

 

-6.7

Age in this study

          

<20

25

0.1

 

20

0.1

 

18

0.1

 

-10.0

20–29

3,208

11.6

 

3,043

11.4

 

2,702

11.2

 

-11.2

30–39

10,010

36.1

 

9,582

36.0

 

8,700

36.1

 

-9.2

40–49

8,497

30.7

 

8,159

30.7

 

7,387

30.6

 

-9.5

>=50

5,966

21.5

 

5,798

21.8

 

5,326

22.1

 

-8.1

Educational level

          

Senior high school or lower

11,494

41.5

 

10,838

40.7

 

9,404

39.0

 

-13.2

College or higher

16,212

58.5

 

15,764

59.3

 

14,729

61.0

 

-6.6

Risk factor

          

MSM

20,230

73.0

 

19,513

73.4

 

17,984

74.5

 

-7.8

Heterosexual (female)

718

2.6

 

690

2.6

 

643

2.7

 

-6.8

Heterosexual (male)

2,996

10.8

 

2,894

10.9

 

2,675

11.1

 

-7.6

IDU

3,718

13.4

 

3,466

13.0

 

2,795

11.6

 

-19.4

Other factors

44

0.2

 

39

0.1

 

36

0.1

 

-7.7

Residence

          

Taipei region

11,333

40.9

 

10,988

41.3

 

10,213

42.3

 

-7.1

Northern region

3,919

14.1

 

3,747

14.1

 

3,331

13.8

 

-11.1

Central region

4,611

16.6

 

4,412

16.6

 

3,956

16.4

 

-10.3

Southern region

2,702

9.8

 

2,583

9.7

 

2,305

9.6

 

-10.8

Kaohsiung and Pingtung region

4,660

16.8

 

4,443

16.7

 

3,963

16.4

 

-10.8

Eastern region

481

1.7

 

429

1.6

 

365

1.5

 

-14.9

Hospital level

          

Medical centre

15,330

55.3

 

14,839

55.8

 

13,746

57.0

 

-7.4

Regional hospital

11,654

42.1

 

11,157

41.9

 

9,930

41.1

 

-11.0

Local hospital

566

2.0

 

527

2.0

 

392

1.6

 

-25.6

Clinic

2

0.0

 

2

0.0

 

2

0.0

 

0.0

Interrupted care

          

No

26,972

97.4

 

26,038

97.9

 

23,702

98.2

 

-9.0

Yes

734

2.6

 

564

2.1

 

431

1.8

 

-23.6

Continual care

          

No

1,778

6.4

 

1,344

5.1

 

747

3.1

 

-44.4

Yes

25,928

93.6

 

25,258

94.9

 

23,386

96.9

 

-7.4

CD4 at the beginning of this study

          

< 350

5,161

18.6

 

4,680

17.6

 

3,637

15.1

 

-22.3

>=350

22,530

81.3

 

21,909

82.4

 

20,484

84.9

 

-6.5

Year in which infection was reported

          

Before 2010

14,161

51.1

 

13,565

51.0

 

12,182

50.5

 

-10.2

After 2010

13,545

48.9

 

13,037

49.0

 

11,951

49.5

 

-8.3

History of drug resistance

          

No

26,297

94.9

 

25,334

95.2

 

23,101

95.7

 

-8.8

Yes

1,409

5.1

 

1,268

4.8

 

1,032

4.3

 

-18.6